OMAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the user's beginner investment knowledge, long-term strategy, and available capital, OMAB is not a strong buy at the moment. Despite solid financial growth and positive analyst sentiment, technical indicators suggest a bearish trend, and there are no immediate catalysts to drive the stock higher. A hold position is recommended until clearer bullish signals emerge.
The MACD is negative and expanding (-2.395), indicating bearish momentum. RSI is neutral at 26.41, and moving averages are converging, showing no clear trend. The stock is trading near its S1 support level of 113.74, with resistance at 122.939. The stock has a 70% probability of declining in the short term (-0.92% in the next day, -4.47% in the next week).
Analysts have raised price targets recently, with Barclays increasing the target to MXN 305 and maintaining an Overweight rating.
Financial performance in Q3 2025 shows strong YoY growth in revenue (+7.88%), net income (+11.04%), and EPS (+10.53%).
Technical indicators suggest bearish momentum.
No recent news or event-driven catalysts to support a bullish move.
Stock trend analysis predicts short-term declines (-4.47% in the next week).
In Q3 2025, revenue increased by 7.88% YoY to 211.12 million, net income rose by 11.04% YoY to 80.83 million, EPS grew by 10.53% YoY to 0.21, and gross margin improved to 66.59%, up 4.85% YoY.
Analysts are positive on OMAB. Barclays raised its price target to MXN 305 and maintains an Overweight rating. Bradesco BBI upgraded the stock to Outperform with a $120 price target. Analysts cite positive developments in the company's master development program and strong financial performance.
